Asthma

An inflammatory condition of the airways, asthma typically presents during childhood. It is very common, and affects hundreds of millions of people worldwide. Asthma is often

...


Read more on Asthma

 

Latest news articles

Added 15 days ago Drug news

Dupixent is filed at EMA as add-on maintenance treatment in certain adults and adolescents (12 years of age and older) with inadequately controlled moderate-to-severe asthma.-Sanofi.

The European Medicines Agency (EMA) has accepted for review an application for Dupixent (dupilumab) as an add-on maintenance treatment in...

Added 1 month ago Drug news

EU approves label update for Relvar Ellipta in asthma.- GlaxoSmithKline + Innoviva.

GlaxoSmithKline and Innoviva announced that the European Commission has approved a label update for the use of once-daily Relvar Ellipta...

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Cystic Fibrosis

Cystic Fibrosis

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.

+ 1 more

Load more

Guidelines

British Guideline on the Management of Asthma

The 2016 update includes a complete revision of the section on diagnosis of asthma and a major update to the section on pharmacological management of asthma as well as revisions to the sections on supported self management...

Added 3 years ago

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

The present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by the German, Austrian and Swiss professional associations for allergy in consensus with the scientific specialist societies and professional associations...

Added 1 year ago

Japanese Guideline for Adult Asthma 2014

Adult bronchial asthma (hereinafter, asthma) is characterized by chronic airway inflammation, reversible airway narrowing, and airway hyperresponsiveness. Long-standing asthma induces airway remodeling to cause intractable asthma.

Added 1 year ago

Search all guidelines for Asthma
 

Journal articles

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies.

Background: Benralizumab is an anti-eosinophilic, anti-interleukin-5 receptor α monoclonal antibody that has been shown to significantly reduce asthma exacerbations and improve lung function for patients with...

Added 1 month ago

Efficacy and safety of benralizumab for eosinophilic asthma: A systematic review and meta-analysis of randomized controlled trials.

Objective: Our systematic review and meta-analysis intends to evaluate the therapeutic efficacy and safety of benralizumab in patients with eosinophilic asthma.

Added 1 month ago

Benralizumab: an anti-IL-5 receptor α monoclonal antibody in the treatment of asthma.

IL-5 is a key cytokine responsible for the maturation, recruitment and survival of eosinophils. The role of eosinophils in pathomechanisms of severe asthma and association of those cells with frequent exacerbations are well accepted.

Added 1 month ago

Search all journal articles for Asthma
 

Clinical trials

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (VENTURE)

Primary Objective:
- To evaluate the efficacy of dupilumab, compared with placebo, for reducing the use of maintenance oral corticosteroids (OCS) in patients with severe steroid-dependent asthma.

Added 5 months ago

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Primary Objective:
- To evaluate the efficacy of dupilumab (SAR231893 / REGN668) in patients with persistent asthma.

Added 7 months ago

Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma (TROPOS)

A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid dependent Asthma.

Added 5 months ago

Search all clinical trials for Asthma
 
Edzard Ernst

researcher and scourge of alternative medicine; >1000 peer-reviewed papers, 49 books [latest: 'A SCIENTIST IN WONDERLAND'], H-Index > 80, retired, now enthusiastic blogger

But he knows nothing about homeopathy!

Whenever I criticise their methods, homeopaths claim that my arguments are invalid because I know next to nothing about the subject. Is this because they feel threatened by my arguments? Or could it be that the allegation is incorrect?

You can judge for yourself - here is a (slightly shortened and revised) excerpt from my recent memoire ‘A SCIENTIST IN WONDERLAND’ which recounts my exposure to and experience in homeopathy.

CME

Respiratory care clinical Q&A November 2015

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Managing Symptomatic Asthma

Managing Symptomatic Asthma
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Easily missed: Occupational asthma

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
0
Registration required
1
Subscription fee
89
Search all CME for Asthma